Prosecution Insights
Last updated: May 29, 2026

Stichting Radboud Universitair Medisch Centrum

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
40% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DAVID, SHAUN L 1 73.0% +19.3%
ENGLE, PATRICIA LYNN 1 62.3% +30.7%
HAN, ROBIN 1 32.2% +60.9%
XU, XIAOYUN 1 59.6% +32.3%
GUSTILO, ESTELLA M 1 52.7% +33.9%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18007849 SOLUBLE TREM-1 AS A MARKER OF SEVERITY OR COMPLICATIONS FOR A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION ENGLE, PATRICIA LYNN 215d overdue
17922987 VAGINAL DEVICE FOR PROLAPSE TREATMENT HAN, ROBIN 111d overdue
17783548 VERSATILE STRATEGY FOR COVALENT GRAFTING OF BIOMOLECULES TO CRYOGELS GUSTILO, ESTELLA M 66d overdue
18258814 Expandable plug DAVID, SHAUN L 13d
17783861 Method for Monitoring of Deep Remissions in Multiple Myeloma and Other Plasma Cell Dyscrasias XU, XIAOYUN 28d

Top Art Units

Art UnitApps
3771 1
3991 1
3786 1
1797 1
1646 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18258814 Expandable plug DAVID, SHAUN L 3771 §103 Non-Final OA 13d Pending Jun 22, 2023
18007849 SOLUBLE TREM-1 AS A MARKER OF SEVERITY OR COMPLICATIONS FOR A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION ENGLE, PATRICIA LYNN 3991 §103 Non-Final OA 215d overdue Pending Dec 02, 2022
17922987 VAGINAL DEVICE FOR PROLAPSE TREATMENT HAN, ROBIN 3786 §103 Non-Final OA 111d overdue Pending Nov 03, 2022
17783861 Method for Monitoring of Deep Remissions in Multiple Myeloma and Other Plasma Cell Dyscrasias XU, XIAOYUN 1797 §103 Non-Final OA 28d Pending Jun 09, 2022
17783548 VERSATILE STRATEGY FOR COVALENT GRAFTING OF BIOMOLECULES TO CRYOGELS GUSTILO, ESTELLA M 1646 §103 Final Rejection 66d overdue Pending Jun 08, 2022

Managing Stichting Radboud Universitair Medisch Centrum's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month